BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Melanoma Research Alliance - Advancing Drug Discovery to Identify 
 New Therapies | Research Funding
DTSTART;VALUE=DATE:20240328
DTSTAMP:20260504T123728Z
UID:918ad5991d5551c86981b32c85b1a629eb15a1a67ec897481e87d3cb
CATEGORIES:Call for proposal
DESCRIPTION:The goal of this RFA is to provide initial support to identify
  new therapeutic modalities including small molecules\, antibodies and cel
 l therapies against validated melanoma targets\; with an emphasis on targe
 ts that are applicable to rare melanoma subtypes. Support from this RFA wi
 ll be geared towards early stages of the drug discovery continuum that cou
 ld result in an optimized lead compound or biologic showing activity in ap
 propriate melanoma preclinical models.\n\nDuration:      1-2 years\n\n
 Funding:       Up to $250\,000 depending on the scope of the research
  project with potential for follow-on funding.\n\nEligibility: Researchers
  and clinicians within or outside the U.S. working in academic medical cen
 ters and universities or other non-profit research institutions are eligib
 le to apply. Principal Investigators must hold a full-time faculty appoint
 ment at the level of Assistant Professor (or equivalent) or above.\n\nHow 
 to Apply: Applications should be submitted the online portal ProposalCentr
 al. Please note that an electronic ‘institutional signature' will be req
 uired to submit the proposal\, please reach out to the Research Office in 
 advance of submission.\n\nApplication Deadline: 28 March 2024\n\nFurther i
 nformation\n\n	More information about the program is available here.\n	The
  online application can be found here.\n	For electronic ‘institutional s
 ignature'\, please contact the Research Office\n	For any other questions\,
  please contact the Research Office.\n\n\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR